Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Yasuda Enterprise Development

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 43
Average round size
info
The average size of a deal this fund participated in
$16M
Portfolio companies 30
Rounds per year 1.87
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.30
Exits 18
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Information Technology
Summary

In 1999 was created Yasuda Enterprise Development, which is appeared as VC. The company was established in North America in United States. The main department of described VC is located in the Menlo Park.

We can highlight the next thriving fund investment areas, such as Pharmaceutical, Hardware. The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Synageva BioPharma, Topica Pharmaceuticals, InPhase Technologies. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Comparing to the other companies, this Yasuda Enterprise Development performs on 10 percentage points more the average number of lead investments. The average startup value when the investment from Yasuda Enterprise Development is 50-100 millions dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2004. The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2013.

The standard case for the fund is to invest in rounds with 7-8 partakers. Despite the Yasuda Enterprise Development, startups are often financed by Oxford Bioscience Partners, Kleiner Perkins, HealthCare Ventures. The meaningful sponsors for the fund in investment in the same round are Japan Asia Investment, HealthCare Ventures, NIF Ventures. In the next rounds fund is usually obtained by Japan Asia Investment, Kleiner Perkins, SMBC Venture Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Yasuda Enterprise Development:
Typical Co-investors
Yasuda Enterprise Development is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Yasuda Enterprise Development:

Funds with similar focus

Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
CEI Community Ventures Oregon, Portland, United States
Cyber Wisdom China, Hong Kong, Kowloon
Esfin Gestion Courbevoie, France, Ile-de-France
Gen3 Partners Boston, Massachusetts, United States
GMH Ventures Newtown Square, Pennsylvania, United States
Gongdao Chuangxin Beijing, Beijing, China
Haitong Kaiyuan Investment China, Shanghai
JFJF Ventures -
Korea Credit Guarantee Fund Daegu, South Korea, Taegu-jikhalsi
Loudwater Investment Partners England, London, United Kingdom
Makeover Solutions New York, New York, United States
Odyssey Investment Partners New York, New York, United States
PlanetM Lansing, Michigan, United States
Ranwa Technologies Co. -
Seed River -
Shangbay Capital California, Palo Alto, United States
Taiwan Tech Arena -
User Local Japan, Tokyo
XFactor Ventures Boston, Massachusetts, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Topica Pharmaceuticals

Biotechnology
Medical Device
Pharmaceutical
$27M18 Oct 2011 Palo Alto, California, United States

Streetmedia

Consumer Reviews
E-Commerce
Retail Technology
Shopping
$455K14 Dec 2009 Chiyoda, Japan

Biotechnology
Medical
Pharmaceutical
$11M03 Sep 2008 San Francisco, California, United States

REGiMMUNE Corporation

Biopharma
Biotechnology
Health Diagnostics
$8M06 May 2008 Chiyoda

REGiMMUNE Corporation

Biopharma
Biotechnology
Health Diagnostics
$6M01 Feb 2008 Chiyoda

NanoGram

Electronics
Manufacturing
Nanotechnology
$32M15 Jan 2008 United States, Milpitas

REGiMMUNE Corporation

Biopharma
Biotechnology
Health Diagnostics
$4M21 Feb 2007 Chiyoda, Japan

Xanthus Pharmaceuticals

Biopharma
Biotechnology
Medical
Pharmaceutical
$25M01 Dec 2006 Cambridge, Massachusetts, United States

Enterprise Software
Manufacturing
Semiconductor
Software
$13M29 Aug 2005 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Yasuda Enterprise Development?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 43
Average round size 16M
Rounds per year 1.87
Peak activity year 2005
Lead investments 1
Follow on index 0.30
Exits 18
Group Appearance index 0.98

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Topica Pharmaceuticals

Biotechnology
Medical Device
Pharmaceutical
$27M18 Oct 2011 Palo Alto, California, United States

Streetmedia

Consumer Reviews
E-Commerce
Retail Technology
Shopping
$455K14 Dec 2009 Chiyoda, Japan

Biotechnology
Medical
Pharmaceutical
$11M03 Sep 2008 San Francisco, California, United States

REGiMMUNE Corporation

Biopharma
Biotechnology
Health Diagnostics
$8M06 May 2008 Chiyoda

REGiMMUNE Corporation

Biopharma
Biotechnology
Health Diagnostics
$6M01 Feb 2008 Chiyoda

NanoGram

Electronics
Manufacturing
Nanotechnology
$32M15 Jan 2008 United States, Milpitas

REGiMMUNE Corporation

Biopharma
Biotechnology
Health Diagnostics
$4M21 Feb 2007 Chiyoda, Japan

Xanthus Pharmaceuticals

Biopharma
Biotechnology
Medical
Pharmaceutical
$25M01 Dec 2006 Cambridge, Massachusetts, United States

Enterprise Software
Manufacturing
Semiconductor
Software
$13M29 Aug 2005 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: